Respiratory carriage of hypervirulent Klebsiella pneumoniae by indigenous populations of Malaysia.


Journal

BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258

Informations de publication

Date de publication:
17 Apr 2024
Historique:
received: 03 10 2023
accepted: 01 04 2024
medline: 19 4 2024
pubmed: 18 4 2024
entrez: 17 4 2024
Statut: epublish

Résumé

Klebsiella pneumoniae is a Gram-negative Enterobacteriaceae that is classified by the World Health Organisation (WHO) as a Priority One ESKAPE pathogen. South and Southeast Asian countries are regions where both healthcare associated infections (HAI) and community acquired infections (CAI) due to extended-spectrum β-lactamase (ESBL)-producing and carbapenem-resistant K. pneumoniae (CRKp) are of concern. As K. pneumoniae can also exist as a harmless commensal, the spread of resistance genotypes requires epidemiological vigilance. However there has been no significant study of carriage isolates from healthy individuals, particularly in Southeast Asia, and specially Malaysia. Here we describe the genomic analysis of respiratory isolates of K. pneumoniae obtained from Orang Ulu and Orang Asli communities in Malaysian Borneo and Peninsular Malaysia respectively. The majority of isolates were K. pneumoniae species complex (KpSC) 1 K. pneumoniae (n = 53, 89.8%). Four Klebsiella variicola subsp. variicola (KpSC3) and two Klebsiella quasipneumoniae subsp. similipneumoniae (KpSC4) were also found. It was discovered that 30.2% (n = 16) of the KpSC1 isolates were ST23, 11.3% (n = 6) were of ST65, 7.5% (n = 4) were ST13, and 13.2% (n = 7) were ST86. Only eight of the KpSC1 isolates encoded ESBL, but importantly not carbapenemase. Thirteen of the KpSC1 isolates carried yersiniabactin, colibactin and aerobactin, all of which harboured the rmpADC locus and are therefore characterised as hypervirulent. Co-carriage of multiple strains was minimal. In conclusion, most isolates were KpSC1, ST23, one of the most common sequence types and previously found in cases of K. pneumoniae infection. A proportion were hypervirulent (hvKp) however antibiotic resistance was low.

Identifiants

pubmed: 38632538
doi: 10.1186/s12864-024-10276-4
pii: 10.1186/s12864-024-10276-4
pmc: PMC11025145
doi:

Substances chimiques

beta-Lactamases EC 3.5.2.6
Carbapenems 0
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

381

Subventions

Organisme : International Medical University
ID : BP I-01/12 (09) 2015
Organisme : International Medical University
ID : BP I-01/12 (09) 2015
Organisme : Newton Fund Institutional Links
ID : 172686537

Informations de copyright

© 2024. The Author(s).

Références

Front Cell Infect Microbiol. 2017 Dec 12;7:515
pubmed: 29312894
J Infect Dis. 2014 Jul 15;210(2):224-33
pubmed: 24495909
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
iScience. 2023 Jun 28;26(7):107215
pubmed: 37496674
BMC Microbiol. 2012 Jan 19;12:13
pubmed: 22260182
Pathogens. 2021 Mar 02;10(3):
pubmed: 33801250
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
Lancet Infect Dis. 2023 Oct;23(10):e431-e444
pubmed: 37148904
Nat Rev Microbiol. 2020 Jun;18(6):344-359
pubmed: 32055025
Sci Total Environ. 2022 Jan 1;802:149859
pubmed: 34464800
Pneumonia (Nathan). 2021 Apr 25;13(1):6
pubmed: 33894778
Nat Commun. 2021 Jul 7;12(1):4188
pubmed: 34234121
Int J Antimicrob Agents. 2022 Aug;60(2):106624
pubmed: 35728713
Emerg Infect Dis. 2001;7(3 Suppl):554-5
pubmed: 11485670
F1000Res. 2019 Feb 11;8:175
pubmed: 31275564
Emerg Infect Dis. 2021 Feb;27(2):443-451
pubmed: 33496247
Malays J Pathol. 2021 Aug;43(2):291-301
pubmed: 34448793
Clin Infect Dis. 2017 Jul 15;65(2):208-215
pubmed: 28369261
Clin Microbiol Rev. 1998 Oct;11(4):589-603
pubmed: 9767057
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Genome Med. 2020 Jan 16;12(1):11
pubmed: 31948471
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Intern Med J. 2022 Jun;52(6):1048-1056
pubmed: 33342052
Sci Rep. 2022 Jul 28;12(1):12939
pubmed: 35902639
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
J Infect. 2015 Nov;71(5):553-60
pubmed: 26304687
NPJ Biofilms Microbiomes. 2021 Jan 5;7(1):1
pubmed: 33402693
PLoS One. 2015 Jul 21;10(7):e0133727
pubmed: 26196384
Lancet. 2016 Jul 9;388(10040):131-57
pubmed: 27108232

Auteurs

Souradeep Das (S)

Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.

Anish K Pandey (AK)

Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University Hospital Southampton Foundation NHS Trust, Southampton, UK.

Denise E Morris (DE)

Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.

Rebecca Anderson (R)

Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.

Victor Lim (V)

School of Medicine, International Medical University, Kuala Lumpur, Malaysia.

Chong Chun Wie (CC)

Institute for Research, Development and Innovation, International Medical University, Kuala Lumpur, Malaysia.
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.

Ivan Kok Seng Yap (IKS)

School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.

Ahmed Ghazi Alattraqchi (AG)

Centre for Research in Infectious Diseases and Biotechnology (CeRIDB), Faculty of Medicine, Universiti Sultan Zainal Abidin, Medical Campus, 20400, Kuala Terengganu, Terengganu, Malaysia.

Hafis Simin (H)

Faculty of Applied Social Sciences, Universiti Sultan Zainal Abidin, Gong Badak Campus, 21300, Kuala Nerus, Terengganu, Malaysia.

Ramle Abdullah (R)

Centre of Excellence in National Indigenous Pedagogy, Institute of Teacher Education Tengku, Ampuan Afzan Campus, Pahang, Malaysia.

Chew Chieng Yeo (CC)

Centre for Research in Infectious Diseases and Biotechnology (CeRIDB), Faculty of Medicine, Universiti Sultan Zainal Abidin, Medical Campus, 20400, Kuala Terengganu, Terengganu, Malaysia.

Stuart C Clarke (SC)

Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University Hospital Southampton Foundation NHS Trust, Southampton, UK.
Institute for Research, Development and Innovation, International Medical University, Kuala Lumpur, Malaysia.
Global Health Research Institute, University of Southampton, Southampton, UK.

David W Cleary (DW)

Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, University of Birmingham, UK. d.w.cleary@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH